Tandem Diabetes receives FDA 510(k) clearance for SteadiSet infusion set for 7-day use

TANDEM DIABETES CARE INC

FDA cleared SteadiSet infusion set for up to seven days of use; features integrated inserter with hidden needle.
SteadiSet designed for type 1 diabetes patients; will be standalone for t:slim X2 and Tandem Mobi pumps.
Also component of future Tandem Mobi tubeless insulin delivery system; manufacturing scale-up underway.
Company expects to launch after scale-up; financial details in future earnings announcements.

item 8.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.